Homocysteine induces tau phosphorylation by inactivating protein phosphatase 2A in rat hippocampus

Neurobiology of Aging

Volumn 29, Issue 11, 2008, Pages 1654-1665

  Zhang, Chang E ^a   Tian, Qing ^a   Wei, Wei ^a   Peng, Jun Hua ^a   Liu, Gong Ping ^a   Zhou, Xin Wen ^a   Wang, Qun ^a   Wang, Dao Wen ^b   Wang, Jian Zhi ^a  

^a HUAZHONG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

^b Institute of Hypertension   (China)

Author keywords

Alzheimer's disease; Homocysteine; Methylation; Phosphorylation; Protein phosphatase 2A; Tau

Indexed keywords

CYANOCOBALAMIN; FOLIC ACID; HOMOCYSTEINE; LEUCINE; PHOSPHOPROTEIN PHOSPHATASE 2A; TAU PROTEIN;

ALZHEIMER DISEASE; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DEMETHYLATION; ENZYME ACTIVATION; ENZYME INACTIVATION; HIPPOCAMPUS; HYPERHOMOCYSTEINEMIA; MALE; NONHUMAN; PRIORITY JOURNAL; PROTEIN LOCALIZATION; RAT;

ANIMALS; ENZYME ACTIVATION; HIPPOCAMPUS; HOMOCYSTEINE; INJECTIONS, INTRAVENOUS; MALE; PHOSPHORYLATION; PROTEIN PHOSPHATASE 2; RATS; RATS, SPRAGUE-DAWLEY; SIGNAL TRANSDUCTION; TAU PROTEINS;

EID: 51649119364     PISSN: 01974580     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neurobiolaging.2007.04.015     Document Type: Article

References (61)

1. Algaidi S.A., Christie L.A., Jenkinson A.M., Whalley L., Riedel G., and Platt B. Long-term homocysteine exposure induces alterations in spatial learning, hippocampal signalling and synaptic plasticity. Exp. Neurol. 197 (2006) 8-21
2. Bhat R.V., Budd Haeberlein S.L., and Avila J. Glycogen synthase kinase 3: a drug target for CNS therapies. J. Neurochem. 89 (2004) 1313-1317
3. Brautigan D.L. Flicking the switches: Phosphorylation of serine/threonine protein phosphatases. Semin. Cancer Biol. 6 (1995) 211-217
4. Bryant J.C., Westphal R.S., and Wadzinski B.E. Methylated C-terminal leucine residue of PP2A catalytic subunit is important for binding of regulatory Bα subunit. Biochem. J. 339 (1999) 241-246
5. Cho U.S., and Xu W. Crystal structure of a protein phosphatase 2A heterotrimeric holoenzyme. Nature 445 (2006) 53-57
6. Clarke R., Smith A.D., Jobst K.A., Refsum H., Sutton L., and Ueland P.M. Folacin, vitamin B12, and serum total homocysteine levels in confirmed Alzheimer disease. Arch. Neurol. 55 (1998) 1449-1455
7. Frick B., Schrocksnadel K., Neurauter G., Wirleitner B., Artner-Dworzak E., and Fuchs D. Rapid measurement of total plasma homocysteine by HPLC. Clin. Chim. Acta 331 (2003) 19-23
8. Goedert M. Tau protein and the neurofibrillary pathology of Alzheimer's disease. Trends Neurosci. 16 (1993) 460-465
9. Gong C.X., Shaikh S., Wang J.Z., Zaidi T., Grundke-Iqbal I., and Iqbal K. Phosphatase activity toward abnormally phosphorylated tau: decrease in Alzheimer disease brain. J. Neurochem. 65 (1995) 732-738
10. Gong C.X., Lidsky T., Wegiel J., Zuck L., Grundke-Iqbal I., and Iqbal K. Phosphorylation of microtubule-associated protein tau is regulated by protein phosphatase 2A in mammalian brain: implications for neurofibrillary degeneration in Alzheimer's disease. J. Biol. Chem. 275 (2000) 5535-5544
11. Gong C.X., Singh T.J., Grundke-Iqbal I., and Iqbal K. Phosphoprotein phosphatase activities in Alzheimer disease brain. J. Neurochem. 61 (1993) 921-927
12. Gong C.X., Singh T.J., Grundke-Iqbal I., and Iqbal K. Alzheimer's disease abnormally phosphorylated tau is dephosphorylated by protein phosphatase-2B (calcineurin). J. Neurochem. 62 (1994) 803-806
13. Grundke-Iqbal I., Iqbal K., Quinlan M., Tung Y.C., Zaidi M.S., and Wisniewski H.M. Microtubule-associated protein tau A component of Alzheimer paired helical filaments. J. Biol. Chem. 261 (1986) 6084-6089
14. Grundke-Iqbal I., Iqbal K., Tung Y.C., Quinlan M., Wisniewski H.M., and Binder L.I. Abnormal phosphorylation of the microtubule-associated protein τ in Alzheimer cytoskeletal pathology. Proc. Natl. Acad. Sci. U.S.A. 83 (1986) 4913-4917
15. Iqbal K., Grundke-Iqbal I., Smith A.J., George L., Tung Y.C., and Zaidi T. Identification and localization of a tau peptide to paired helical filaments of Alzheimer disease. Proc. Natl. Acad. Sci. U.S.A. 86 (1989) 5646-5650
16. Iwatsubo T., Odaka A., Suzuki N., Mizusawa H., Nukina N., and Ihara Y. Visualization of Aβ42(43) and Aβ40 in senile plaques with end-specific Aβ monoclonals: evidence that an initially deposited species is Aβ42(43). Neuron 13 (1994) 45-53
17. Janssens V., and Goris J. Protein phosphatase 2A: a highly regulated family of serine/threonine phosphatases implicated in cell growth and signalling. Biochem. J. 353 (2001) 417-439
18. Kim J.M., Lee H., and Chang N. Hyperhomocysteinemia due to short-term folate deprivation is related to electron microscopic changes in the rat brain. J. Nutr. 132 (2002) 3418-3421
19. Kruman I.I., Kumaravel T.S., Lohani A., Pedersen W.A., Cutler R.G., Kruman Y., Haughey N., Lee J., Evans M., and Mattson M.P. Folic acid deficiency and homocysteine impair DNA repair in hippocampal neurons and sensitize them to amyloid toxicity in experimental models of Alzheimer's disease. J. Neurosci. 22 (2002) 1752-1762
20. Lee H., Kim H.J., Kim J.M., and Chang N. Effects of dietary folic acid supplementation on cerebrovascular endothelial dysfunction in rats with induced hyperhomocysteinemia. Brain Res. 996 (2004) 139-147
21. Lee J., Chen Y., Tolstykh T., and Stock J. A specific protein carboxyl methylesterase that demethylates phosphoprotein phosphatase 2A in bovine brain. Proc. Natl. Acad. Sci. U.S.A. 93 (1996) 6043-6047
22. Lee J., and Stock J. Protein phosphatase 2A catalytic subunit is methyl-esterified at its carboxyl terminus by a novel methyltransferase. J. Biol. Chem. 268 (1993) 19192-19195
23. Lee V.M., Balin B.J., Otvos Jr. L., and Trojanowski J.Q. A68: a major subunit of paired helical filaments and derivatized forms of normal Tau. Science 251 (1991) 675-678
24. Levitt A.J., and Karlinsky H. Folacin, vitamin B12 and cognitive impairment in patients with Alzheimer's disease. Acta Psychiatr. Scand. 86 (1992) 301-305
25. Li X., Lu F., Wang J.Z., and Gong C.X. Concurrent alterations of O-GlcNAcylation and phosphorylation of tau in mouse brains during fasting. Eur. J. Neurosci. 23 (2006) 2078-2086
26. Liu F., Grundke-Iqbal I., Iqbal K., and Gong C.X. Contributions of protein phosphatases PP1, PP2A PP2B and PP5 to the regulation of tau phosphorylation. Eur. J. Neurosci. 22 (2005) 1942-1950
27. Liu R., Pei J.J., Wang X.C., Zhou X.W., Tian Q., Winblad B., and Wang J.Z. Acute anoxia induces tau dephosphorylation in rat brain slices and its possible underlying mechanisms. J. Neurochem. 94 (2005) 1225-1234
28. Liu S.J., Zhang J.Y., Li H.L., Fang Z.Y., Wang Q., Deng H.M., Gong C.X., Grundke-Iqbal I., Iqbal K., and Wang J.Z. Tau becomes a more favorable substrate for GSK3 when it is prephosphorylated by PKA in rat rain. J. Biol. Chem. 279 (2004) 50078-50088
29. Mattson M.P., and Shea T.B. Folacin and homocysteine metabolism in neural plasticity and neurodegenerative disorders. Trends Neurosci. 26 (2003) 137-146
30. McCaddon A., Davies G., Hudson P., Tandy S., and Cattell H. Total serum homocysteine in senile dementia of Alzheimer type. Int. J. Geriatr. Psychiatry 13 (1998) 235-239
31. Merrick S.E., Trojanowski J.Q., and Lee V.M. Selective destruction of stable microtubules and axons by inhibitors of protein serine/threonine phosphatases in cultured human neurons. J. Neurosci. 17 (1997) 5726-5737
32. Nilsson K., Gustafson L., and Hultberg B. Plasma homocysteine, cobalamin/folate status, and vascular disease in a large population of psychogeriatric patients. Dement. Geriatr. Cogn. Disord. 22 (2006) 358-366
33. Obeid R., and Herrmann W. Mechanisms of homocysteine neurotoxicity in neurodegenerative diseases with special reference to dementia. FEBS Lett. 580 (2006) 2994-3005
34. Pacheco-Quinto J., Rodriguez de Turco E.B., DeRosa S., Howard A., Cruz-Sanchez F., Sambamurti K., Refolo L., Petanceska S., and Pappolla M.A. Hyperhomocysteinemic Alzheimer's mouse model of amyloidosis shows increased brain amyloid β peptide levels. Neurobiol. Dis. 22 (2006) 651-656
35. Planel E., Yasutake K., Fujita S.C., and Ishiguro K. Inhibition of protein phosphatase 2A overrides tau protein kinase I/glycogen synthase kinase 3β and cyclin-dependent kinase 5 inhibition and results in tau hyperphosphorylation in the hippocampus of starved mouse. J. Biol. Chem. 276 (2001) 34298-34306
36. Ravaglia G., Forti P., Maioli F., Martelli M., Servadei L., Brunetti N., Porcellini E., and Licastro F. Homocysteine and folacin as risk factors for dementia and Alzheimer disease. Am. J. Clin. Nutr. 82 (2005) 636-643
37. Sasaki K., Duan J., Murohara T., Ikeda H., Shintani S., Shimada T., Akita T., Egami K., and Imaizumi T. Rescue of hypercholesterolemia-related impairment of angiogenesis by oral folate supplementation. J. Am. Coll. Cardiol. 42 (2003) 364-372
38. Schild A., Ittner L.M., and Gotz J. Altered phosphorylation of cytoskeletal proteins in mutant protein phosphatase 2A transgenic mice. Biochem. Biophys. Res. Commun. 343 (2006) 1171-1178
39. Schnyder G., Roffi M., Pin R., Flammer Y., Lange H., Eberli F.R., Meier B., Turi Z.G., and Hess O.M. Decreased rate of coronary restenosis after lowering of plasma homocysteine levels. N. Engl. J. Med. 345 (2001) 1593-1600
40. Selhub J., Jacques P.F., Bostom A.G., D'Agostino R.B., Wilson P.W., Belanger A.J., O'Leary D.H., Wolf P.A., Schaefer E.J., and Rosenberg I.H. Association between plasma homocysteine concentrations and extracranial carotid-artery stenosis. N. Engl. J. Med. 332 (1995) 286-291
41. Selley M.L., Close D.R., and Stern S.E. The effect of increased concentrations of homocysteine on the concentration of (E)-4-hydroxy-2-nonenal in the plasma and cerebrospinal fluid of patients with Alzheimer's disease. Neurobiol. Aging 23 (2002) 383-388
42. Seshadri S., Beiser A., Selhub J., Jacques P.F., Rosenberg I.H., D'Agostino R.B., Wilson P.W., and Wolf P.A. Plasma homocysteine as a risk factor for dementia and Alzheimer's disease. N. Engl. J. Med. 346 (2002) 476-483
43. Sontag E. Protein phosphatase 2A: The Trojan Horse of cellular signaling. Cell Signal 13 (2001) 7-16
44. Sontag E., Hladik C., Montgomery L., Luangpirom A., Mudrak I., Ogris E., and White III C.L. Downregulation of protein phosphatase 2A carboxyl methylation and methyltransferase may contribute to Alzheimer disease pathogenesis. J. Neuropathol. Exp. Neurol. 63 (2004) 1080-1091
45. Sontag E., Nunbhakdi-Craig V., Lee G., Bloom G.S., and Mumby M.C. Regulation of the phosphorylation state and microtubule-binding activity of tau by protein phosphatase 2A. Neuron 6 (1996) 1201-1207
46. Sontag E., Nunbhakdi-Craig V., Lee G., Brandt R., Kamibayashi C., Kuret J., White C.L., Mumby III M.C., and Bloom G.S. Molecular interactions among phosphatase 2A, tau, and micro-tubules: implications for the regulation of tau phosphorylation and the development of tauopathies. J. Biol. Chem. 274 (1999) 25490-25498
47. Sun L., Liu S.Y., Zhou X.W., Wang X.C., Liu R., Wang Q., and Wang J.Z. Inhibition of protein phosphatase 2A- and protein phosphatase 1-induced tau hyperphosphorylation and impairment of spatial memory retention in rats. Neuroscience 118 (2003) 1175-1182
48. Tabet N., Rafi H., Weaving G., Lyons B., and Iversen S.A. Behavioural and psychological symptoms of Alzheimer type dementia are not correlated with plasma homocysteine concentration. Dement. Geriatr. Cogn. Disord. 22 (2006) 432-438
49. Tian Q., Lin Z.Q., Wang X.C., Chen J., Wang Q., Gong C.X., and Wang J.Z. Injection of okadaic acid into the meynert nucleus basalis of rat brain induces decreased acetylcholine level and spatial memory deficit. Neuroscience 126 (2004) 277-284
50. Tian Q., and Wang J.Z. Role of serine/threonine protein phosphatase in Alzheimer's Disease. Neurosignals 11 (2002) 262-269
51. Tolstykh T., Lee J., Vafai S., and Stock J.B. Carboxyl methylation regulates phosphoprotein phosphatase 2A by controlling the association of regulatory B subunits. EMBO J. 19 (2000) 5682-5691
52. Trojanowski J.Q., and Lee V.M. Phosphorylation of paired helical filament tau in Alzheimer's disease neurofibrillary lesions: focusing on phosphatases. FASEB J. 9 (1995) 1570-1576
53. Vafai S.B., and Stock J.B. Protein phosphatase 2A methylation: a link between elevated plasma homocysteine and Alzheimer's Disease. FEBS Lett. 518 (2002) 1-4
54. Vogelsberg-Ragaglia V., Schuck T., Trojanowski J.Q., and Lee V.M. PP2A mRNA expression is quantitatively decreased in Alzheimer's disease hippocampus. Exp. Neurol. 168 (2001) 402-412
55. Wang J.Z., Gong C.X., Zaidi T., Grundke-Iqbal I., and Iqbal K. Dephosphorylation of Alzheimer paired helical filaments by protein phosphatase-2A and 2B. J. Biol. Chem. 270 (1995) 4854-4860
56. Wang J.Z., Grundke-Iqbal I., and Iqbal K. Kinases and phosphatases and tau sites involved in Alzheimer neurofibrillary degeneration. Eur. J. Neurosci. 25 (2007) 59-68
57. Welsh G.N., and Loscalzo J. Homocysteine and atherothrombosis. N. Engl. J. Med. 338 (1998) 1042-1050
58. Wu J., Tolstykh T., Lee J., Boyd K., Stock J.B., and Broach J.R. Carboxyl methylation of the phosphoprotein phosphatase 2A catalytic subunit promotes its functional association with regulatory subunits in vivo. EMBO J. 19 (2000) 5672-5681
59. Xu Y.H., Xing Y.N., Chen Y., Chao Y., Lin Z., Fan E., Yu W.J., Strack S., Jeffrey P.D., and Shi Y.G. Structure of the protein phosphatase 2A holoenzyme. Cell 127 (2006) 1239-1251
60. Yu X.X., Du X., Moreno C.S., Green R.E., Ogris E., Feng Q., Chou L., McQuoid M.J., and Pallas D.C. Methylation of the protein phosphatase 2A catalytic subunit is essential for association of Bα regulatory subunit but not SG2NA, striatin, or polyomavirus middle tumor antigen. Mol. Biol. Cell 12 (2001) 185-199
61. Zhang Y.J., Xu Y.F., Liu Y.H., Yin J., Li H.L., Wang Q., and Wang J.Z. Peroxynitrite induces Alzheimer-like tau modifications and accumulation in rat brain and its underlying mechanisms. FASEB J. 20 (2006) 1431-1442